Condition: Chronic Obstructive Pulmonary Disease · COPD Exacerbation · Sponsor: Clinact
The hypothesis of this study is that any of 3 modalities of home non- invasive ventilation (NIV) compared to 'no NIV' (=hospital NIV) will reduce re-admission to hospital or death in COPD patients who remain persistently hypercapnic following an exacerbation requiring NIV.
This description comes directly from the study's public registry record.
Angèle Guilbot · +33-180-13-15-19 · angele.guilbot@multihealthgroup.com
Nathalie Gagne · +33-180-13-14-70 · nathalie.gagne@clinact.com
Always discuss trial participation with your own doctor first.
| Groupe Hospitalier Pitié Salpêtrière-Charles Foix | Paris, Île-de-France Region, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03890224